Acute Pulmonary Embolism
Clinical research includes intermediate-high risk acute pulmonary embolism, with attention to outcomes such as cardiorespiratory decompensation, recurrence, and mortality in patients managed with catheter-directed thrombolysis and anticoagulation.
- Thromboembolic disease
- Pulmonary vascular intervention
- Cardiopulmonary complications
The focus is on treatment strategies for patients at elevated risk of clinical deterioration in acute venous thromboembolic disease.
Critical Care Gastrointestinal Disorders
Another area of interest is postantibiotic diarrhoea in critically ill patients, addressing bowel dysfunction that emerges after antibiotic exposure in intensive care settings.
- Intensive care medicine
- Antibiotic-associated diarrhoea
- Gastrointestinal microbiota
Research activity in this field reflects interest in restoring intestinal function and reducing treatment failure in severely ill hospitalised patients.
Microbiome-Based Therapy
The sponsor also supports work involving healthy donor stool transfer to the patient gut, pointing to therapeutic interest in faecal microbiota transplantation and related microbiome restoration approaches.
- Gut microbiome
- Donor-derived microbial therapy
- Infectious and post-infectious bowel symptoms
This area connects infectious disease recovery with interventions aimed at re-establishing a balanced intestinal microbial environment.
